A "catastrophic hypothesis" for pancreas cancer progression

Gastroenterology

Volumn 124, Issue 7, 2003, Pages 1958-1964

  Real, Francisco X ^a,b  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN INK4A; PTOTEIN TP53; SMAD4 PROTEIN; UNCLASSIFIED DRUG;

AUTOPSY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER INVASION; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; CARCINOGENESIS; CARCINOMA IN SITU; CAUSE OF DEATH; DNA METHYLATION; EARLY DIAGNOSIS; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; METASTASIS; MOLECULAR MODEL; NONHUMAN; ONCOGENE K RAS; PANCREAS CANCER; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SQUAMOUS CELL METAPLASIA; TELOMERE; TUMOR VOLUME;

EID: 0037944148     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(03)00389-5     Document Type: Review

References (47)

1. AGA (American Gastroenterological Association). American Gastroenterological Association medical position statement: epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology 1999;117:1463-1484.
2. Bast RC, Kufe DW, Pollock RE, Weichselbaum RR, Holland JF, Frei E. Cancer Medicine, 5th ed. Ontario, Canada, 2000.
3. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-170.
4. Hruban RH, Goggins M, Parsons J, Kern SE. Progression model for pancreatic cancer. Clin Cancer Res 2000;6:2969-2972.
5. Jaffee EM, Hruban RH, Canto M, Kern SE. Focus on pancreas cancer. Cancer Cell 2002;2:25-28.
6. Hruban RH, Adsay NV, Albores-Saavedra J, Compton D, Garrett ES, Goodman SN, Kern SE, Klimstra DS, Klöppel G, Longnecker DS, Lüttges J, Offerhaus GJA. Pancreatic intraepithelial neoplasia. A new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001;25:579-586.
7. Luttges J, Reinecke-Luthge A, Mollmann B, Menke MA, Clemens A, Klimpfinger M, Sipos B, Kloppel G. Duct changes and K-ras mutations in the disease-free pancreas: analysis of type, age relation and spatial distribution. Virchows Arch 1999;435:461-468.
8. Pour PM, Sayed S, Sayed G. Hyperplastic, preneoplastic and neoplastic lesions found in 83 human pancreases. Am J Clin Pathol 1982;77:137-152.
9. Tomioka T, Andren-Sandberg A, Fujii H, Egami H, Takiyama Y, Pour PM. Comparative histopathological findings in the pancreas of cigarette smokers and non-smokers. Cancer Lett 1990;55: 121-128.
10. Cubilla AL, Fitzgerald PJ. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res 1976;36:2690-2698.
11. Kimura W, Morikane K, Esaki Y, Chan WC, Pour PM. Histologic and biologic patterns of microscopic pancreatic ductal adenocarcinomas detected incidentally at autopsy. Cancer 1998;82: 1839-1849.
12. Ishii T, Maeda K, Nakamura K, Hosoda Y. Cancer in the aged: an autopsy study of 940 cancer patients. J Am Geriatr Soc 1979; 27:307-313.
13. Gezelius C, Eriksson A. Neoplastic disease in a medicolegal autopsy material. A retrospective study in northern Sweden. Z Rechtsmed 1988;101:115-130.
14. Lee YS. Incidental carcinoma of the colorectum at autopsy and its effects on the incidence and future trends of colorectal cancers in Singapore. Cancer 1988;61:1059-1064.
15. Ueyama T, Yoshida M, Motooka M, Kitagawa S, Masuda K, Tsuneyoshi M. Colorectal carcinomas incidentally detected in autopsied cases and in patients. Am J Gastroenterol 1991;86: 1795-1799.
16. Vatn M, Stalsberg H. The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer 1982;49:819-825.
17. Rickert RR, Auerbach O, Garfinkel L, Hammond EC, Frasca JM. Adenomatous lesions of the large bowel: an autopsy survey. Cancer 1979;43:1847-1857.
18. Williams AR, Balasooriya BA, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut 1982;23:835-842.
19. Terhune PG, Phifer DM, Tosteson TD, Longnecker DS. K-ras mutations in focal proliferative lesions of human pancreas. Cancer Epidemiol Biomarkers Prev 1998;7:515-521.
20. Tsuchiya R, Noda T, Harada N, Miyamoto T, Tomioda T, Yamamoto K, Yamaguchi T, Izawa K, Tsunoda T, Yoshin R. Collective review of small carcinomas of the pancreas. Ann Surg 1986;203:77-81.
21. Tsuchiya R, Tajima Y, Matsuzaki S, Onizuka S, Kanematsu T. Early pancreatic cancer. Pancreatology 2001;1:597-603.
22. Pongprasobchai S, Pitchumoni S, Smyrk TC. Small pancreatic cancer: a less aggressive cancer? (abstr) Pancreas 2002;45: 445.
23. Cameron JL, Crist DW, Sitzmann JV, Hruban RH, Boitnott JK, Seidler AJ, Coleman J. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 1991;161: 120-124.
24. Capellari JO, Geisinger KR, Albertson DA, Wolfman NT, Kute KE. Malignant papillary cystic tumor of the pancreas. Cancer 1990; 66:193-198.
25. Barbe L, Levy P, Mal F, Gayet B. Tumeur intra-canalaire papillaire mucineuse pancréatique bénigne, évoluant depuis 30 années. Gastroenterol Clin Biol 1998;22:91-93.
26. Maire F, Hammel P, Terris B, Paye F, Scoazec JY, Cellier C, Barthet M, O'Toole D, Rufat P, Partensk C, Cuillerier E, Levy P, Belghiti J, Ruszniewski P. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut 2002;51:717-722.
27. Brat DJ, Lillemoe KID, Yeo CJ, Warfield PB, Hruban RH. Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. Am J Surg Pathol 1998;22:163-169.
28. Yanagisawa A, Ohtak K, Ohashi K, Hori M, Kitagawa T, Sugano H, Kato Y. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res 1993;53:953-956.
29. Schutte M, Hruban RH, Geradts J, Maynard R, Hilgers W, Rabindran SK, Moskaluk CA, Hahn SA, Schwarte-Waldhoff I, Schmiegel W, Baylin SB, Kern SE, Herman JG. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res 1997;57:3126-3130.
30. Wilentz RE, Geradts J, Maynard R, Offerhaus GJA, Kang M, Goggins M, Yeo CJ, Kern SE, Hruban RH. Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res 1998;58:4740-4744.
31. Moskaluk CA, Hruban RH, Kern SE. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res 1997;57:2140-2143.
32. Lüttges J, Galehdari H, Bröcker V, Schwarte-Waldholff I, Henne-Bruns D, Klöppel G, Schmiegel W, Hahn SA. Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. Am J Pathol 2001;158:1677-1683.
33. Yamano M, Fujii H, Takagaki T, Kadowaki N, Watanabe H, Shirai T. Genetic progression and divergence in pancreatic carcinoma. Am J Pathol 2000;156:2123-2133.
34. Fukushima N, Sato N, Ueki T, Rosty C, Walter KM, Wilentz RE, Yeo CJ, Hruban RH, Goggins M. Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Am J Pathol 2002;160: 1573-1581.
35. WAF1/CIP1 is an early event in the development of pancreatic intraepithelial neoplasia. Cancer Res 2001;61:8830-8837.
36. Wilentz RE, Iacobuzio-Donahue CA, Argani P, McCarthy DM, Parsons JL, Yeo CJ, Kern SE, Hruban RH. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res 2000; 60:2002-2006.
37. Hruban RH, Wilentz RE, Kern SE. Genetic progression in the pancreatic ducts. Am J Pathol 2000;156:1821-1825.
38. Barbera VM, Malats N, Porta M, Corominas JM, Salas A, Guarner L, Rifǎ J, Lemoine NR, Carrato A, Real FX. Almost universal inactivation of the Tp53 gene in exocrine pancreatic cancer: analysis using laser microdissection. 2003 (Submitted for publication).
39. Wagner M, Greten FR, Weber CK, Koschnick S, Mattfeld T, Deppert W, Kern H, Adler G, Schmid R. A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease. Genes Dev 2001;15:286-293.
40. Bardeesy N, Morgan J, Sinha M, Signoretti S, Srivastava S, Loda M, Merlino G, DePinho RA. Obligate roles for p16 (Ink4a) and 19(Arf)-p53 in the suppression of murine pancreatic neoplasia. Mol Cell Biol 2002;22:635-643.
41. Tjarda van Heek N, Meeker AK, Kern SE, Yeo CJ, Lillemoe KD, Cameron JL, Offerhaus GJA, Hicks JL, Wilentz RE, Goggins MG, De Marzo AM, Hruban RH, Maitra A. Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. Am J Pathol 2002;161:1541-1547.
42. Kayahara M, Nagakawa T, Konishi I, Ueno K, Ohta T, Miyazaki I. Clinicopathological study of pancreatic carcinoma with particular reference to the invasion of the extrapancreatic neural plexus. Int J Pancreatol 1991;10:105-111.
43. Villers A, McNeal JE, Redwine EA, Freiha FS, Stamey TA. The role of perineural space invasion in the local spread of prostatic adenocarcinoma. J Urol 1989;142:763-768.
44. Klein AP, Hruban RH, Brune KA, Petersen GM, Goggins M. Familial pancreatic cancer. Cancer J 2001;7:266-273.
45. Ulrich CD. Pancreatic cancer in hereditary pancreatitis: consensus guidelines for prevention, screening, and treatment. Pancreatology 2001;1:416-422.
46. Kern S, Hruban R, Hollingsworth MA, Brand R, Adrian TE, Jaffee E, Tempero MA. A white paper: the product of a pancreas cancer think tank. Cancer Res 2001;61:4923-4932.
47. Kim SK, MacDonald RJ. Signalling and transcriptional control of pancreatic organogenesis. Curr Opin Genet Dev 2002;12:540-547.